Danaher Corporation $DHR Stock Sold by Jacobi Capital Management LLC

Jacobi Capital Management LLC decreased its position in shares of Danaher Corporation (NYSE:DHR) by 38.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,796 shares of the conglomerate’s stock after selling 3,697 shares during the period. Jacobi Capital Management LLC’s holdings in Danaher were worth $1,284,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Machina Capital S.A.S. bought a new stake in shares of Danaher in the 3rd quarter worth approximately $1,519,000. Riverbridge Partners LLC grew its holdings in shares of Danaher by 9.0% during the 3rd quarter. Riverbridge Partners LLC now owns 243,517 shares of the conglomerate’s stock valued at $53,951,000 after purchasing an additional 20,113 shares during the last quarter. Silver Grove Financial Group Inc. grew its holdings in shares of Danaher by 27.5% during the 3rd quarter. Silver Grove Financial Group Inc. now owns 408 shares of the conglomerate’s stock valued at $90,000 after purchasing an additional 88 shares during the last quarter. AMG National Trust Bank raised its position in Danaher by 1.9% in the 3rd quarter. AMG National Trust Bank now owns 18,411 shares of the conglomerate’s stock worth $4,079,000 after purchasing an additional 344 shares during the period. Finally, Csenge Advisory Group raised its position in Danaher by 105.3% in the 3rd quarter. Csenge Advisory Group now owns 4,749 shares of the conglomerate’s stock worth $1,052,000 after purchasing an additional 2,436 shares during the period. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other news, EVP Gregory M. Milosevich sold 2,100 shares of the stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $230.62, for a total transaction of $484,302.00. Following the completion of the sale, the executive vice president directly owned 22,367 shares in the company, valued at approximately $5,158,277.54. This represents a 8.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Christopher Bouda sold 7,598 shares of the firm’s stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares in the company, valued at $2,136,137.92. The trade was a 45.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 10.80% of the stock is currently owned by insiders.

Danaher Stock Down 1.4%

Shares of Danaher stock opened at $232.08 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock has a market capitalization of $163.28 billion, a price-to-earnings ratio of 37.98, a P/E/G ratio of 2.95 and a beta of 0.76. The company’s 50 day moving average price is $222.11 and its 200-day moving average price is $201.53.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company had revenue of $6.55 billion during the quarter, compared to analyst estimates of $6.56 billion. During the same period in the prior year, the business posted $1.89 EPS. The firm’s revenue was up 8.3% compared to the same quarter last year. Equities research analysts forecast that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were given a $0.40 dividend. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s payout ratio is presently 26.19%.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent research reports. Morgan Stanley boosted their price target on shares of Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research note on Monday, October 12th. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Monday, October 26th. The Goldman Sachs Group reiterated a “buy” rating and issued a $275.00 price objective on shares of Danaher in a report on Thursday, October 22nd. Wells Fargo & Company decreased their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Finally, Weiss Ratings raised Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. Eighteen analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $242.91.

About Danaher

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.